文献速递流行病学与生物统计基础与转化研究

基因预测睾酮与血栓栓塞、心力衰竭及心肌梗死的关联:英国生物银行孟德尔随机化研究

Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank.
PubMed 文献 · BMJ · 2019-03-06

该研究采用两样本孟德尔随机化方法,利用JMJD1C基因区域变异作为工具变量,在英国生物银行等数据中分析内源性睾酮与血栓栓塞、心力衰竭和心肌梗死的因果关系。结果显示,在男性中基因预测睾酮与血栓栓塞(OR 2.09,95%CI 1.27-3.46)和心力衰竭(OR 7.81,95%CI 2.56-23.8)正相关,但与心肌梗死无显著关联;验证研究中与心肌梗死正相关(OR 1.37,95%CI 1.03-1.82)。

要点

  • 在男性中,基因预测睾酮与血栓栓塞和心力衰竭风险呈正相关。
  • 基因预测睾酮与男性心肌梗死无显著关联,但验证研究中呈正相关。
  • SHBG基因区域潜在多效性变异预测的睾酮与结局无关联。

核心结论

  • 内源性睾酮与男性血栓栓塞、心力衰竭和心肌梗死呈正相关。
  • 内源性睾酮可通过现有治疗控制,可能是血栓栓塞和心力衰竭的可改变危险因素。

研究设计与样本

  • 两样本孟德尔随机化研究,使用受孕时随机分配的遗传变异作为工具变量推断因果关系。
  • 数据来源包括REDUCE随机对照试验(3225名50-75岁欧洲裔男性)、英国生物银行(392038名40-69岁英国白人男女)和CARDIoGRAMplusC4D 1000 Genomes基于的全基因组关联研究(171875名约77%欧洲血统参与者,用于验证)。

主要发现

  • 英国生物银行参与者中,13691例血栓栓塞(男性6208例,女性7483例),1688例心力衰竭(男性1186例,女性502例),12882例心肌梗死(男性10136例,女性2746例)。
  • 在男性中,JMJD1C基因区域变异预测的基因睾酮与血栓栓塞正相关(对数转化睾酮每单位增加OR 2.09,95%CI 1.27-3.46),与心力衰竭正相关(OR 7.81,95%CI 2.56-23.8),与心肌梗死无显著关联(OR 1.17,95%CI 0.78-1.75)。
  • 在女性中关联较不明显。
  • 验证研究中,JMJD1C基因区域变异预测的睾酮与心肌梗死正相关(OR 1.37,95%CI 1.03-1.82)。
  • 遗传变异与结局的关联中未观察到过度异质性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether endogenous testosterone has a causal role in thromboembolism, heart failure, and myocardial infarction. DESIGN: Two sample mendelian randomisation study using genetic variants as instrumental variables, randomly allocated at conception, to infer causality as additional randomised evidence. SETTING: Reduction by Dutasteride of Prostate Cancer Events (REDUCE) randomised controlled trial, UK Biobank, and CARDIoGRAMplusC4D 1000 Genomes based genome wide association study. PARTICIPANTS: 3225 men of European ancestry aged 50-75 in REDUCE; 392 038 white British men and women aged 40-69 from the UK Biobank; and 171 875 participants of about 77% European descent, from CARDIoGRAMplusC4D 1000 Genomes based study for validation. MAIN OUTCOME MEASURES: Thromboembolism, heart failure, and myocardial infarction based on self reports, hospital episodes, and death. RESULTS: Of the UK Biobank participants, 13 691 had thromboembolism (6208 men, 7483 women), 1688 had heart failure (1186, 502), and 12 882 had myocardial infarction (10 136, 2746). In men, endogenous testosterone genetically predicted by variants in the JMJD1C gene region was positively associated with thromboembolism (odds ratio per unit increase in log transformed testosterone (nmol/L) 2.09, 95% confidence interval 1.27 to 3.46) and heart failure (7.81, 2.56 to 23.8), but not myocardial infarction (1.17, 0.78 to 1.75). Associations were less obvious in women. In the validation study, genetically predicted testosterone (based on JMJD1C gene region variants) was positively associated with myocardial infarction (1.37, 1.03 to 1.82). No excess heterogeneity was observed among genetic variants in their associations with the outcomes. However, testosterone genetically predicted by potentially pleiotropic variants in the SHBG gene region had no association with the outcomes. CONCLUSIONS: Endogenous testosterone was positively associated with thromboembolism, heart failure, and myocardial infarction in men. Rates of these conditions are higher in men than women. Endogenous testosterone can be controlled with existing treatments and could be a modifiable risk factor for thromboembolism and heart failure.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Luo S, Au Yeung SL, Zhao JV, et al. Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank. BMJ. 2019. PMID: 30842065. doi:10.1136/bmj.l476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。